CovidArray: A Microarray-Based Assay with High Sensitivity for the Detection of Sars-Cov-2 in Nasopharyngeal Swabs
Título
CovidArray: A Microarray-Based Assay with High Sensitivity for the Detection of Sars-Cov-2 in Nasopharyngeal Swabs
Autor
Silvia Galbiati, Francesco Damin, Laura Sola, Marcella Chiari, Stella Gagliardi, Cristina Cereda, Francesca Dragoni, Claudio Fenizia, Valeria Savasi
Descripción
A new coronavirus (SARS-CoV-2) caused the current coronavirus disease (Covid-19) epidemic. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is used as the gold standard for clinical detection of SARS-CoV-2. Under ideal conditions, RT-qPCR Covid-19 assays have analytical sensitivity and specificity greater than 95%. However, when the sample panel is enlarged including asymptomatic individuals, the sensitivity decreases and false negatives are reported. Moreover, RT-qPCR requires up to 3–6 h with most of the time involved in RNA extraction from swab samples. We introduce CovidArray, a microarray-based assay, to detect SARS-CoV-2 markers N1 and N2 in the nasopharyngeal swabs. The method is based on solid-phase hybridization of fluorescently-labeled amplicons upon RNA extraction and reverse transcription. This approach combines the physical-optical properties of the silicon substrate with the surface chemistry used to coat the substrate to obtain a diagnostic tool of great sensitivity. Furthermore, we used an innovative approach, RNAGEM, to extract and purify viral RNA in less than 15 min. We correctly assigned 12 nasopharyngeal swabs, previously analyzed by RT-qPCR. Thanks to the CovidArray sensitivity we were able to identify a false-negative sample. CovidArray is the first DNA microarray-based assay to detect viral genes in the swabs. Its high sensitivity and the innovative viral RNA extraction by RNAGEM allows the reduction of both the amount of false-negative results and the total analysis time to about 2 h.
Fecha
2021
Materia
Molecular diagnostics, covid-19, SARS-CoV-2, RT-qPCR, microarray, microarray-based assay
Identificador
10.3390/s21072490
Fuente
Epidemiology and Health
Editor
Korean Society of Epidemiology
Cobertura
Chemical technology
Colección
Citación
Silvia Galbiati, Francesco Damin, Laura Sola, Marcella Chiari, Stella Gagliardi, Cristina Cereda, Francesca Dragoni, Claudio Fenizia, Valeria Savasi, “CovidArray: A Microarray-Based Assay with High Sensitivity for the Detection of Sars-Cov-2 in Nasopharyngeal Swabs,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/6894.
Position: 14050 (21 views)